Wells Fargo & Company »

Oncternal Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.3k 300 7.60
2024-03-31 $2.9k 322 9.00

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth Call Option (UNH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wells Fargo & Company

Top funds holding Oncternal Therapeutics

Vanguard Group
Millennium Management
BlackRock
Dimensional Fund Advisors
Geode Capital Management
Pasadena Private Wealth
Richmond Brothers
Renaissance Technologies
Susquehanna International
Morgan Stanley
Quantum Private Wealth
Acadian Asset Management
Jpmorgan Chase & Co
Tower Research Capital
Wells Fargo & Company

View all funds holding Oncternal Therapeutics